Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Synokem gets CDSCO Panel nod to manufacture and market FDC Nortriptyline,Gabapentin

Susmita Roy7 July 2022 6:30 PM IST

New Delhi: Pharmaceutical major, Synokem Pharmaceuticals has got the go ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard...

Drug-makers to add Hyponatraemia as adverse effect in package insert of Olanzapine: CDSCO Panel

Susmita Roy5 July 2022 6:00 PM IST

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...

Add Haloperidol linked cogwheel rigidity in package insert: CDSCO Panel

Susmita Roy3 July 2022 11:00 AM IST

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO...

NPPA fixes retail price of 84 formulations, Details

Susmita Roy2 July 2022 7:14 PM IST

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...

Glenmark gets CDSCO Panel nod to study antidiabetic FDC containing Dapagliflozin, Sitagliptin, Metformin

Susmita Roy27 Jun 2022 6:15 PM IST

New Delhi: Granting the waiver of bioequivalence study, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO)...

CDSCO issues Medical Device Alert for Cordis palmaz genesis peripheral stent

Susmita Roy26 Jun 2022 12:00 PM IST

New Delhi: In line with the Risk Assessment Form released by Cordis Cashel, Ireland, the Central Drugs Standard Control Organization (CDSCO) has...

These 300 medicines have been finalised for QR code

Susmita Roy17 Jun 2022 6:00 PM IST

New Delhi: Amending the Drug Rules 1945, through a recent Gazette Notification, the Ministry of Health and Family Welfare (MoHFW) has issued a draft...

Drug alert: CDSCO flags 41 medicine batches as not of standard quality

Susmita Roy11 Jun 2022 6:35 PM IST

New Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 41...

Teva resolves patent dispute with Aurobindo pharma over Huntingtons disease drug AUSTEDO

Susmita Roy10 Jun 2022 7:06 PM IST

Bringing the long argument to a conclusion, Teva Branded Pharmaceutical Products R&D, and Auspex Pharmaceuticals,U.S. affiliates of Teva...

HC restrains pharma companies from infringing Boehringer Ingelheim diabetes drug Linagliptin

Susmita Roy8 Jun 2022 4:04 PM IST

New Delhi: In a major relief to pharmaceuticals major Boehringer Ingelheim, the High Court has restrained four domestic pharma companies namely,...

Drug-Makers to add urinary retention as ADR in package insert of Tramadol

Susmita Roy6 Jun 2022 7:23 PM IST

New Delhi: Deliberating the signal review panel (SRP) recommendation received from Pharmacovigilance Programme of India (PvPI), the Subject Expert...

Jazz Pharmas Ziihera Gets USFDA Nod To Treat HER2-Positive Biliary Tract Cancer

Drug-makers to add Candidiasis as adverse event in Patient Information Leaflet of anticancer drug Docetaxal: CDSCO Panel

Susmita Roy5 Jun 2022 11:00 AM IST

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok